Literature DB >> 33908651

Congenital, acquired, or both? The only two congenitally based, acquired heart diseases.

Nikolaos A Papakonstantinou1, Meletios A Kanakis1, Dimitrios Bobos1, Nicholas M Giannopoulos1.   

Abstract

Discrete subaortic stenosis (DSS) is a type of left ventricular outflow tract obstruction whereas double-chambered right ventricle is a form of right ventricular outflow tract obstruction. Both of these cardiac malformations share lots of similar characteristics which classify them as acquired developmental heart diseases despite their congenital anatomical substrate. Both of them are frequently associated to ventricular septal defects. The initial stimulus in their pathogenetic process is anatomical abnormalities or variations. Subsequently, a hemodynamic process is triggered finally leading to an abnormal subaortic fibroproliferative process with regard to DSS or to hypertrophy of ectopic muscles as far as double-chambered right ventricle is concerned. In many cases, these pathologies are developed secondarily to surgical management of other congenital or acquired heart defects. Moreover, high recurrence rates after initial successful surgical therapy, particularly regarding DSS, have been described. Finally, an interesting coexistence of DSS and double-chambered aortic ventricle has also been reported in some cases.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  acquired heart disease; congenital heart disease; discrete subaortic stenosis; double-chambered right ventricle; left ventricular outflow tract obstruction; right ventricular outflow tract obstruction

Mesh:

Year:  2021        PMID: 33908651     DOI: 10.1111/jocs.15588

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  1 in total

1.  Spontaneous closure of an isolated congenital perimembranous ventricular septal defect in two dogs.

Authors:  Anne van de Watering; Viktor Szatmári
Journal:  BMC Vet Res       Date:  2022-05-03       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.